Action PAREXEL INTERNATIONAL CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués PAREXEL International Corporation

Actions

US6994621075

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Parexel : Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships
BU
PAREXEL International : Launches Perceptive® Cloud for the Life Sciences Industry
BU
PAREXEL International : Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry
BU
PAREXEL International : Pamplona Capital Management Completes Acquisition of PAREXEL International
BU
PAREXEL International : Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management
BU
PAREXEL International : Medical Research Stock Performance Review -- Exact Sciences, DexCom, and PAREXEL
PR
PAREXEL International : Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments
BU
PAREXEL International : Reports Fourth Quarter and Fiscal Year 2017 Results
BU
PAREXEL International : Announces Date of Fourth Quarter and Fiscal Year 2017 Earnings Release
BU
PAREXEL International : and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
BU
PAREXEL International Corporation : Announces $720 Million Senior Notes Offering by West Street Merger Sub, Inc.
BU
PAREXEL International : Two PAREXEL Executives Named to 2017 PharmaVOICE 100
BU
PAREXEL International : Receives CEO Cancer Gold Standard Re-Accreditation
BU
PAREXEL International : Named to the Forbes America’s Best Employers List for Second Consecutive Year
BU
Brower Piven Commences an Investigation into the Proposed Sale of PAREXEL International Corporation and Encourages Investors to Contact the Firm for Additional Information
BU
PAREXEL INTERNATIONAL CORPORATION Former SEC Attorney Willie Briscoe Investigates Sale to Pamplona Capital Management, LLP
BU
PAREXEL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PAREXEL International Corporation
PR
PAREXEL International : Enters Definitive Agreement to Be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash
BU
PAREXEL International : Alberto Grignolo Named Fellow by Drug Information Association
PU
PAREXEL International : Introduces Its Connected Journey™ of Newly Integrated Data-Driven Services to Simplify Drug Development and Commercialization
BU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action
  4. Actualités PAREXEL International Corporation
  5. Communiqués